Bio-Path Holdings (BPTH)
(Delayed Data from NSDQ)
$2.78 USD
-0.40 (-12.58%)
Updated Jun 6, 2024 04:00 PM ET
Pre-Market: $2.73 -0.05 (-1.80%) 9:18 AM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/20/24 |
---|---|
Current Quarter | -2.06 |
EPS Last Quarter | -4.88 |
Last EPS Surprise | -7.49% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -9.68 |
Next Year | -8.00 |
EPS (TTM) | -40.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.06 | -1.95 | -9.68 | -8.00 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.06 | -1.95 | -9.68 | -8.00 |
High Estimate | -2.06 | -1.95 | -9.68 | -8.00 |
Low Estimate | -2.06 | -1.95 | -9.68 | -8.00 |
Year ago EPS | -10.60 | -6.40 | -33.63 | -9.68 |
Year over Year Growth Est. | 80.57% | 69.53% | 71.22% | 17.36% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.06 | -1.95 | -9.68 | -8.00 |
7 Days Ago | -2.06 | -1.95 | -9.68 | -8.00 |
30 Days Ago | -4.60 | -4.71 | -18.71 | -18.41 |
60 Days Ago | -4.60 | -4.71 | -18.71 | -18.41 |
90 Days Ago | -5.00 | -5.40 | -20.80 | -15.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.06 | -1.95 | -9.68 | -8.00 |
Zacks Consensus Estimate | -2.06 | -1.95 | -9.68 | -8.00 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.88 | NA | -6.40 | -10.60 | NA |
Estimate | -4.54 | NA | -6.80 | -10.40 | NA |
Difference | -0.34 | NA | 0.40 | -0.20 | -0.05 |
Surprise | -7.49% | NA | 5.88% | -1.92% | -1.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more